Spreading Depression: Mechanism of Action in Neuroinflammatory Diseases DOI Creative Commons

Arezou Eshaghabadi Niasari,

Ali Gorji, Hanieh Jalali

и другие.

The Neuroscience Journal of Shefaye Khatam, Год журнала: 2023, Номер 11(4), С. 108 - 124

Опубликована: Окт. 1, 2023

Introduction: Spreading Depression (SD) is a pathophysiological phenomenon that occurs as transient wave of depolarization neurons and glial cells, results in temporary suppression the activity neurons.In this phenomenon, there disturbance distribution balance ions between extracellular intracellular environments cellular metabolism.Furthermore, SD accompanied by short increase bioelectrical activity, followed strong depression neuronal long-term excitability network.Recently, neuroinflammatory function one main contributors to neurological diseases, has been widely investigated.The role revealed some such migraine with aura, epilepsy, global amnesia, cerebrovascular including cerebral ischemia-infarction stroke, well intracranial hemorrhage caused traumatic head injury.Conclusion: Despite large growing body evidence, exact mechanism propagation still not clear requires more indepth investigations.Therefore, review, we discuss underlying highlight development diseases.

Язык: Английский

Nitroaromatic-Based Triazene Prodrugs to Target the Hypoxic Microenvironment in Glioblastoma DOI
Cláudia Braga, Margarida Silva, M. Luísa Corvo

и другие.

RSC Medicinal Chemistry, Год журнала: 2025, Номер 16(3), С. 1350 - 1362

Опубликована: Янв. 1, 2025

Nitroaromatic-based triazene prodrugs elicited enhanced cytotoxicity and apoptosis in hypoxic LN-229 glioblastoma cells comparing to temozolomide, highlighting their therapeutic potential for multiforme.

Язык: Английский

Процитировано

0

Natural Source of Drugs Targeting Central Nervous System Tumors—Focus on NAD(P)H Oxidoreductase 1 (NQO1) Activity DOI Creative Commons
Nikola M. Stojanović,

M Mitić,

Jovan Ilić

и другие.

Brain Sciences, Год журнала: 2025, Номер 15(2), С. 132 - 132

Опубликована: Янв. 29, 2025

Central nervous system (CNS) tumors involve a large and diverse group of malignancies that arise from various cell types within the brain tissue. Although there are advances in treatments, CNS still remain challenging, due to their complex biology delicate nature surrounding NAD(P)H O=oxidoreductase 1 (NQO1) is an enzyme plays critical role detoxification quinones, protecting cells oxidative stress. In this often overexpressed, which contributes resistance tumor chemotherapy by enhancing antioxidant defenses. NQO1 influences progression affecting downstream signaling pathways, such as those involving transcription factor SNAIL, well others associated with behavior. Plants represent valuable source numerous constituents different chemical structures known affect molecular pathways pathologies.

Язык: Английский

Процитировано

0

Perivascular glial reactivity is a feature of phosphorylated tau lesions in chronic traumatic encephalopathy DOI Creative Commons

Chelsie Osterman,

Danica Hamlin,

Catherine M. Suter

и другие.

Acta Neuropathologica, Год журнала: 2025, Номер 149(1)

Опубликована: Фев. 8, 2025

Chronic traumatic encephalopathy (CTE), a neurodegenerative disease associated with repetitive head injuries, is characterised by perivascular hyperphosphorylated tau (p-tau) accumulations within the depths of cortical sulci. Although majority CTE literature focuses on p-tau pathology, other pathological features such as glial reactivity, vascular damage, and axonal damage are relatively unexplored. In this study, we aimed to characterise these features, specifically in lesion areas, better understand microenvironment surrounding lesion. We utilised multiplex immunohistochemistry investigate distribution 32 different markers cytoarchitecture pathology that relevant both brain injury neurodegeneration. qualitatively assessed images measured percentage area labelling for each marker non-lesion areas cases. identified reactivity prominent feature lesions, largely driven increases astrocyte compared areas. Furthermore, astrocytes labelled NAD(P)H quinone dehydrogenase 1 (NQO1) L-ferritin, indicating lesion-associated may be compensatory response iron-induced oxidative stress. Our findings demonstrate inflammation consistent pathognomonic contribute pathogenesis injury-related

Язык: Английский

Процитировано

0

A Proteomic Study Based on Home Quarantine Model Identifies NQO1 and Inflammation Pathways Involved in Adenoid Hypertrophy DOI Creative Commons
Penghui Chen, Shule Hou, Xiuhong Pang

и другие.

Journal of Inflammation Research, Год журнала: 2025, Номер Volume 18, С. 723 - 735

Опубликована: Янв. 1, 2025

Adenoid hypertrophy is a common disorder of childhood, and has an unclear pathogenesis. At the beginning COVID-19 pandemic, there was significant reduction in incidence adenoid children under long-term home quarantine, providing rare research model to explore pathogenesis treatment targets adenoidal children. Before during quarantine period, adenoids that underwent surgery were detected using label-free proteomics. Differences protein expression analyzed Gene Ontology, Kyoto Encyclopedia Genes Genomes, Set Enrichment Analysis, Protein-protein interaction, immunohistochemistry analysis. Long-term had profound impact on proteomics pediatric adenoids, with up-regulated down-regulated proteins 28 92 downregulated proteins, respectively. Functional enrichment analysis showed differentially expressed mainly enriched pathways such as leukocyte activation, inflammatory response, IL-1 production, Th17 cell differentiation, IL-17 signaling. In group, inflammation-related (TNF-α, IL-6), CD36, S100A2, considerably reduced, whereas NQO1 levels increased significantly, potentially alleviating hypertrophy. NQO1, NDUFS8, NDUFAF2 exhibited strong interactions. This study identified some candidate differential inflammation involved preschool

Язык: Английский

Процитировано

0

Prodrugs and their activation mechanisms for brain drug delivery DOI Creative Commons

Ida Aaberg Lillethorup,

Andreas Victor Hemmingsen,

Katrine Qvortrup

и другие.

RSC Medicinal Chemistry, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Prodrugs are masked drugs that first become pharmacologically active after undergoing a structural change in vivo. They designed to improve physicochemical/biopharmaceutical drug properties and increase site specificity. The prodrug approach is important when developing brain-targeting due the presence of brain barriers seriously limit entry highly polar, multifunctional entities. While several excellent reviews summarize modifications facilitating transport across barriers, summary mechanisms used for activation missing. Given high need innovative discoveries development, we here review most tools being developed since 2000 CNS activation.

Язык: Английский

Процитировано

0

Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease DOI Creative Commons
Taylor R. Church, Seth S. Margolis

Frontiers in Cell and Developmental Biology, Год журнала: 2025, Номер 12

Опубликована: Фев. 7, 2025

Neurodegenerative diseases are characterized by the progressive breakdown of neuronal structure and function pathological accumulation misfolded protein aggregates toxic oligomers. A major contributor to deterioration physiology is disruption catabolic pathways mediated proteasome, a large protease complex responsible for most cellular degradation. Previously, it was believed that proteolysis proteasome required tagging targets with polyubiquitin chains, pathway called ubiquitin-proteasome system (UPS). Because this, research on proteasomal roles in neurodegeneration has historically focused UPS. However, additional ubiquitin-independent their importance increasingly recognized. In this review, we discuss range pathways, focusing substrate identification targeting, regulatory molecules adaptors, activators alternative caps, diverse complexes including 20S membrane immunoproteasome, extracellular proteasomes, hybrid proteasomes. These further discussed context aging, oxidative stress, aggregation, age-associated neurodegenerative diseases, special focus Alzheimer's Disease, Huntington's Parkinson's Disease. mechanistic understanding regulation critical development therapies treat these devastating conditions. This review summarizes current state neurodegeneration.

Язык: Английский

Процитировано

0

Ozone: complicated effects in central nervous system diseases DOI

Xu Zhang,

Shijun Wang,

Si-Cen Wan

и другие.

Medical Gas Research, Год журнала: 2024, Номер 15(1), С. 44 - 57

Опубликована: Окт. 2, 2024

Oxidative stress is closely related to various diseases. Ozone can produce redox reactions through its unique response. As a source of the oxidative response, strong oxidizing nature ozone cause severe damage body. On other hand, low concentrations activate mechanisms combat and achieve therapeutic effects. Some animal experiments clinical studies have revealed potential medical value ozone, indicating that not just toxic gas. By reviewing mechanism in treating central nervous system diseases (especially ischemic stroke Alzheimer’s disease) effects we find inhalation lack antioxidants or excessive exposure lead harmful impacts. However, with adequate antioxidants, transmit signals, reduce inflammation, amyloid β peptide levels, improve tissue oxygenation. Similar those possible new drugs for disease indicate ozone. Nevertheless, limited research has restricted application More are needed reveal exact dose–effect relationship healing effect

Язык: Английский

Процитировано

1

SP600125, a selective JNK inhibitor, is a potent inhibitor of NAD(P)H: quinone oxidoreductase 1 (NQO1) DOI
Bingling Zhong, Yifei Zhang, Haoyi Zheng

и другие.

Acta Pharmacologica Sinica, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 25, 2024

Язык: Английский

Процитировано

1

Ferroptosis suppressor protein 1 regulated oligodendrocytes ferroptosis rescued by idebenone in spinal cord injury DOI Creative Commons

Baoyou Fan,

Derong Liu,

Jia Qin

и другие.

Free Radical Biology and Medicine, Год журнала: 2024, Номер 227, С. 129 - 142

Опубликована: Дек. 1, 2024

Язык: Английский

Процитировано

1

Emerging role of Nrf2 in Parkinson’s disease therapy: a critical reassessment DOI
Veerta Sharma, Prateek Sharma, Thakur Gurjeet Singh

и другие.

Metabolic Brain Disease, Год журнала: 2024, Номер 40(1)

Опубликована: Дек. 19, 2024

Язык: Английский

Процитировано

1